We are live on ! Find out more
SC

Searle & Co Portfolio holdings

AUM $445M
1-Year Est. Return 41.72%
This Fund
S&P 500
This Quarter Est. Return
+6.87%
1 Year Est. Return
+41.72%
3 Year Est. Return
+93.84%
5 Year Est. Return
+130.57%
10 Year Est. Return
+365.42%
AUM
$104M
AUM Growth
+$6.94M
Cap. Flow
+$2.78M
Cap. Flow %
2.67%
Top 10 Hldgs %
32.54%
Holding
115
New
11
Increased
40
Reduced
21
Closed
4

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.08M
2
GE icon
GE Aerospace
GE
+$745K
3
GSK icon
GSK
GSK
+$697K
4
XOM icon
ExxonMobil
XOM
+$430K
5
JNJ icon
Johnson & Johnson
JNJ
+$352K

Sector Composition

Rank Sector Weight
1 Healthcare 25.86%
2 Energy 14.81%
3 Financials 10.04%
4 Industrials 9.49%
5 Technology 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETP
101
DELISTED
Energy Transfer Partners L.p.
ETP
$212K 0.2%
6,068
+740
+14% +$29K
DHR icon
102
Danaher
DHR
$137B
$209K 0.2%
+3,398
New +$213K
PAA icon
103
Plains All American Pipeline
PAA
$17.3B
$209K 0.2%
8,600
-1,125
-12% -$30.3K
CDK
104
DELISTED
CDK Global, Inc.
CDK
$208K 0.2%
4,433
GMLP
105
DELISTED
Golar LNG Partners LP
GMLP
$188K 0.18%
14,335
-3,000
-17% -$45.1K
ET icon
106
Energy Transfer Partners
ET
$70.1B
$141K 0.14%
10,000
GMZ
107
DELISTED
Goldman Sachs MLP Income Opportunities Fund
GMZ
$129K 0.12%
+2,143
New +$154K
AVP
108
DELISTED
Avon Products, Inc.
AVP
$73K 0.07%
18,000
OIL
109
DELISTED
Barclays Bank PLC iPath Exchange Traded Notes Linked to Goldman Sachs Crude Oil Total Return In
OIL
$63K 0.06%
10,000
-25,500
-72% -$197K
WINT
110
DELISTED
Windtree Therapeutics Inc
WINT
$29K 0.03%
9,893
CGNT
111
DELISTED
Cogentix Medical, Inc.
CGNT
$12K 0.01%
10,000
GSK icon
112
GSK
GSK
$104B
-14,500
Closed -$697K
MO icon
113
Altria Group
MO
$114B
-4,522
Closed -$246K
WMB icon
114
Williams Companies
WMB
$87.5B
-5,808
Closed -$214K
NGLS
115
DELISTED
TARGA RESOURCES PARTNERS LP COM UTS REPTG LTD PARTERSHIP INT
NGLS
-8,996
Closed -$261K

Similar funds

Searle & Co's Q4 2015 Portfolio in Review

As of Q4 2015, Searle & Co held 115 positions worth $104M, up 7.1% from $97.3M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Searle & Co's Q4 2015 filing shows 11 new, 40 increased, 21 reduced and 4 closed positions. Its largest new stake was RH: 4,250 shares worth $332K. The largest sale was Pfizer, an estimated $1.08M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 27% a quarter earlier, followed by Energy and Financials.

  • Searle & Co's largest Q4 2015 buy was RH: 4,250 shares worth $332K.
  • Searle & Co added most to Yum! Brands in Q4 2015, an estimated $542K increase.
  • Searle & Co's biggest Q4 2015 reduction was Pfizer, cutting an estimated $1.08M.
  • Searle & Co fully exited GSK in Q4 2015, selling an estimated $697K.
  • Searle & Co's ten largest holdings make up 33% of its $104M portfolio in Q4 2015.
  • Searle & Co opened 11 new positions and closed 4 in Q4 2015.
  • Searle & Co's portfolio value rose 7.1% quarter-over-quarter to $104M.

Based on Searle & Co's 13F filing for Q4 2015, filed 11 Jan 2016.